Guangdong Zhongsheng Pharmaceutical Co Ltd (002317):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9411
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangdong Zhongsheng Pharmaceutical Co Ltd (Guangdong Zhongsheng Pharma) is a pharmaceutical company that develops, manufactures and supplies Chinese patent medicines, medicinal herbs and chemical medicines. The company offers its products in the form of tablets, capsules, pills, injections, oral solutions, ear and eye drops, cream and gels, lotion, suspensions and others. Its products are used for the prevention and treatment of ophthalmology, cardiovascular and cerebrovascular diseases, respiratory diseases, digestive diseases, diabetes, tumours and senile degenerative diseases, among others. Guangdong Zhongsheng Pharma sells its products throughout China. The company operates its subsidiaries in China. Guangdong Zhongsheng Pharma is headquartered in Dongguan, China.

Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangdong Zhongsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Guangdong Zhongsheng Pharmaceutical Signs Cooperation Agreement with Shanghai WuXi PharmaTech 11
Equity Offering 12
Guangdong Zhongsheng Pharma Amends Terms of Private Placement of Shares for USD157.2 Million 12
Debt Offering 13
Guangdong Zhongsheng Pharma to Raise up to USD191.6 Million in Public Offering of Notes Due 2022 13
Acquisition 14
Guangdong Zhongsheng to Acquire 80.5% Stake in Guangdong Based Pharmaceutical Company for USD63.7 Million 14
Guangdong Zhongsheng Pharma to Acquire Remaining 2.31% Stake in Strong Pharma for USD4.8 Million 15
Guangdong Zhongsheng Pharma to Acquire 97.69% Stake in Strong Pharma for USD206 Million 16
Guangdong Zhongsheng Pharma Completes Acquisition Of 51.46% Stake In China-Based Medicine Company For US$4 Million 17
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Hubei Based Company For US$13 Million 18
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Zhanyi Based Company For US$4.9 Million 19
Guangdong Zhongsheng Pharmaceutical Co Ltd – Key Competitors 20
Guangdong Zhongsheng Pharmaceutical Co Ltd – Key Employees 21
Guangdong Zhongsheng Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangdong Zhongsheng Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Guangdong Zhongsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Guangdong Zhongsheng Pharmaceutical Signs Cooperation Agreement with Shanghai WuXi PharmaTech 11
Guangdong Zhongsheng Pharma Amends Terms of Private Placement of Shares for USD157.2 Million 12
Guangdong Zhongsheng Pharma to Raise up to USD191.6 Million in Public Offering of Notes Due 2022 13
Guangdong Zhongsheng to Acquire 80.5% Stake in Guangdong Based Pharmaceutical Company for USD63.7 Million 14
Guangdong Zhongsheng Pharma to Acquire Remaining 2.31% Stake in Strong Pharma for USD4.8 Million 15
Guangdong Zhongsheng Pharma to Acquire 97.69% Stake in Strong Pharma for USD206 Million 16
Guangdong Zhongsheng Pharma Completes Acquisition Of 51.46% Stake In China-Based Medicine Company For US$4 Million 17
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Hubei Based Company For US$13 Million 18
Guangdong Zhongsheng Pharma To Acquire 51% Stake In Zhanyi Based Company For US$4.9 Million 19
Guangdong Zhongsheng Pharmaceutical Co Ltd, Key Competitors 20
Guangdong Zhongsheng Pharmaceutical Co Ltd, Key Employees 21

List of Figures
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Guangdong Zhongsheng Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Guangdong Zhongsheng Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Guangdong Zhongsheng Pharmaceutical Co Ltd (002317):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Erste Group Bank AG:企業の戦略・SWOT・財務分析
    Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report Summary Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務情報
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Iridium Communications Inc (IRDM):企業の財務・戦略的SWOT分析
    Iridium Communications Inc (IRDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Infinity Energy Resources Inc (IFNY):企業の財務・戦略的SWOT分析
    Summary Infinity Energy Resources Inc (Infinity Energy) is an oil and gas company that offers exploration and development of crude oil resources. The company operates oil and gas concessions located at offshore Nicaragua in the Caribbean Sea. Its concessions are located adjacent to Noble Energy’s of …
  • Petronet LNG Ltd (PETRONET):企業の財務・戦略的SWOT分析
    Petronet LNG Ltd (PETRONET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bharat Dynamics Limited
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Japan Display Inc:企業の戦略・SWOT・財務情報
    Japan Display Inc - Strategy, SWOT and Corporate Finance Report Summary Japan Display Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Magellan Midstream Partners, L.P.:企業の戦略・SWOT・財務情報
    Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • CTI BioPharma Corp (CTIC):製薬・医療:M&Aディール及び事業提携情報
    Summary CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company, which acquires, develops, and commercializes targeted therapies for a range of blood-related cancers. The company’s lead product, Pixuvri (pixantrone) is an aza-anthracenedione used for the treatment of multiply relapsed or r …
  • Snap-on Incorporated (SNA):企業の財務・戦略的SWOT分析
    Snap-on Incorporated (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Noerr LLP:企業の戦略的SWOT分析
    Noerr LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Entravision Communications Corp (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • De Lage Landen International B.V.:企業の戦略・SWOT・財務情報
    De Lage Landen International B.V. - Strategy, SWOT and Corporate Finance Report Summary De Lage Landen International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Verbund AG (VER)-エネルギー分野:企業M&A・提携分析
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor t …
  • Siemens Gamesa Renewable Energy SA (SGRE):企業の財務・戦略的SWOT分析
    Siemens Gamesa Renewable Energy SA (SGRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Singulex Inc-製薬・医療分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) operates as a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆